Iron, infection and anemia - A classical triade;Eisen, infektion und anämie - Eine klassische triade

Wiener Klinische Wochenschrift

Volumn 114, Issue 10-11, 2002, Pages 357-367

  Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anemia of chronic disease; Erythropoetin; Hemochromatosis; Macrophage; Salmonella

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GAMMA INTERFERON; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CELLULAR IMMUNITY; CHRONIC DISEASE; HEMOCHROMATOSIS; IMMUNOSURVEILLANCE; INFECTION; IRON TRANSPORT; MACROPHAGE; REVIEW; SALMONELLA; TUMOR CELL;

ANEMIA, HYPOCHROMIC; BACTERIAL INFECTIONS; CYTOKINES; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; HEME; HEMOCHROMATOSIS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IRON; MACROPHAGES; NEOPLASMS;

EID: 0037076925     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Free radicals and phagocytic cells
2. Iron is hot: Update on the pathophysiology of hemochromatosis
3. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
4. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor
5. A novel MHC class I like gene is mutated in patients with hereditary haemochromatosis
6. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with β2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells
7. Cloning and characterization of a mammalian proton-coupled metal-ion transporter
8. Haemochromatosis in the new millennium
9. Duodenal metal-transporter (DMT-1) expression in patients with hereditary hemochromatosis
10. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
11. Iron acquisition by the reticuloendothelial system
12. Lactoferrin. A multifunctional immunoregulatory protein?
13. Regulation of iron metabolism in eukaryotes
14. Molecular control of vertebrate iron metabolism: mRNA based regulatory circuits operated by iron, nitric oxide and oxidative stress
15. IRP-1 binding to ferritin mRNA prevents the recruitment of the small ribosomal subunit by the cap-binding complex elF4F
16. Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA
17. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmatic transferrin receptor mRNA
18. Nitric oxide and macrophage function
19. Nitric oxide and the regulation of gene expression
20. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway
21. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages
22. Rapid responses to oxidative stress mediated by iron regulatory protein
23. The Th1/Th2 paradigm
24. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor
25. Ferritin synthesis in inflammation. Mechanism of increased ferritin synthesis
26. The molecular cloning and characterization of ferritin heavy chain, a tumor necrosis factor inducible gene
27. Interleukin I induces ferritin heavy chain in human muscle cells
28. Ferritin translation by Interleukin-1 and interleukin-6: The role of sequences upstream of the start codons of the heavy and light subunit genes
29. Tumor necrosis factor-α and interleukin 1-α regulate transferrin receptor in human diploid fibroblasts
30. Interferon-gamma and lipopolysaccharide regulate the expression of Nramp2 and increase the uptake of iron from low relative molecular mass complexes by macrophages
31. Regulation of iron transport by inflammatory cytokines in human monocytic cells
32. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13
33. Regulation of iron metabolism in murine J774 macrophages: Role of nitric oxide dependent and independent pathways following activation with gamma interferon and lipopolysaccharide
34. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: Changes in transferrin uptake, iron handling and ferritin mRNA
35. Regulation of transferrin receptor expression and ferritin content in human mononuclear macrophages. Coordinate upregulation by iron transferrin and downregulation by interferon gamma
36. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter
37. A novel duodenal iron-regulated transporter, 1REG 1, implicated in the basolateral transfer of iron to the circulation
38. A novel mammalian iron-regulated protein involved in intracellular iron metabolism
39. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse
40. Iron in infection, immunity, inflammation and neoplasia
41. Linkage of cellular immunity to iron metabolism
42. Lymphocyte proliferation is controlled both by iron availability and regulation of iron uptake pathways
43. Iron and lymphocytes: Reciprocal regulatory interactions
44. Role of iron in T cell activation: Th-1 clones differ from Th-2 clones in their sensitivity to inhibition for DNA synthesis caused by IGG MAbs against transferrin receptor and the iron chelator desferrioxamine
45. Iron modulates interferon-γ effects in the human myelomonocytic cell line THP-1
46. Response of monocyte iron regulatory protein activity to inflammation: Abnormal behavior in genetic hemochromatosis
47. Neopterin as marker for activation of cellular immunity: Immunologic basis and clinical application
48. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity
49. Iron overload alters T helper cell responses to Candida albicans in mice
50. Iron and immunity - A two-sided sword
51. Iron regulates nitric oxide synthase activity by controlling nuclear transcription
52. Functional requirement of the hypoxia responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine
53. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression
54. Iron loading and disease surveillance
55. Body iron stores and the risk of cancer
56. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria
57. Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria
58. Regulatory interactions between iron and nitric oxide metabolism for immune defense against plasmodium falciparum infection
59. Serum neopterin, interleukin-4, and interleukin-6 concentrations in cerebral malaria patients and the effect of iron chelation therapy
60. Role of iron in the natural history and clinical course of hepatitis C disease
61. Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection
62. Iron enhances hepatitis C virus replication in cultured human hepatocytes
63. Chronic hepatitis C treated with phlebotomy alone: Biochemical and histological outcome
64. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial
65. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited
66. Role of iron in experimental Mycobacterium avium infection
67. Understanding the multiple functions of NRAMP1
68. Divalent metal transport by NRAMP proteins at the interface to host-pathogen interaction
69. The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens
70. A negative autoregulatory link between Nramp1 function and expression
71. Iron status and the outcome of HIV infection: An overview
72. Pathobiology of the role of iron in infection
73. Iron withholding: A defense against infection and neoplasia
74. Metal ion transport in eukaryotic microorganisms: Insights from Saccharornyces cerevisiae
75. Emerging strategies in microbial haem capture
76. Immune response to intracellular bacteria
77. The anaemia of inflammation and chronic disease
78. Progress in understanding the pathogenesis of the anemia of chronic disease
79. Iron and the anemia of chronic disease
80. Iron release from human monocytes after erythrophagocytosis in vitro: An investigation in normal subjects and hereditary hemochromatosis patients
81. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes
82. Interferongamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development
83. Nitric oxide suppression of human hematopoiesis in vitro
84. Serum levels of erythropoietin and selected cytokines in patients with anemia of chronic disease
85. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic onset juvenile chronic arthritis
86. Decreased erythropoietin response in patients with anemia of cancer
87. Inhibition of human erythroid colony formation by IFN-gamma can be corrected by human recombinant erythropoietin
88. Erythropoietin response in anemia patients with multiple myeloma and other lymphoid malignancies infiltrating the bone marrow
89. Availability of iron and degree of inflammation modifies the response to recombinant erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis
90. Inhibition of in vitro erythropoiesis by soluble mediators of Plasmodium chabaudi AS malaria: Lack of a major role of interleukin 1, tumor necrosis factor alpha, and gamma interferon
91. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency
92. Zinc protoporphyrin in anemia of chronic disorders
93. Hypochromic red blood cells and reticulocytes
94. Anemia in critical illness
95. Infliximab therapy for ulcerative colitis: Many unanswered questions
96. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis
97. Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction?
98. Non-infectious complications of transfusion therapy
99. Effect of transfusional iron overload on immune response
100. Erythropoietin: A paradigm for the development of practice guidelines
101. Prediction of response to erythropoietin treatment in chronic anemia of cancer
102. Importance of iron supply for erythropoietin therapy
103. Reduction in recombinant human erythropoeitin doses by the use of chronic intravenous iron supplementation
104. Regulation of cellular iron metabolism by erythropoietin: Activation of iron regulatory protein and up-regulation of transferrin-receptor in erythroid cells
105. Complex regulation of transferrin receptors during erythropoietin-induced differentiation of J2E erythroid cells
106. Role of iron in optimizing responses of cancer patietns to erythropoietin